Medicare Enrolled
Dr. Jon Haddad, M.D.
Orthopedic Surgery · Amarillo, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Haddad from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Haddad? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Haddad
Dr. Jon Haddad is an orthopedic surgery in Amarillo, TX, with 20 years in practice. Based on federal Medicare data, Dr. Haddad performed 9,867 Medicare services across 4,226 unique beneficiaries.
Between the years covered by Open Payments, Dr. Haddad received a total of $29,033 from 44 pharmaceutical and/or device companies across 526 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in orthopedic surgery. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Haddad is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 2% volume in TX$ $29,033 industry payments
Medicare Practice Summary
Medicare Utilization ↗9,867
Medicare services
Top 2% in TX for orthopedic surgery
4,226
Unique beneficiaries
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~493 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 2,215 | $90 | $259 |
| Contrast dye for imaging (iodine-based) | 2,203 | $0 | $2 |
| Electrocardiogram (EKG), 12-lead | 1,367 | $10 | $63 |
| EKG interpretation and report | 687 | $6 | $37 |
| Chronic care management, first 20 min/month | 507 | $35 | $100 |
| Anticoagulant management of patient taking warfarin | 483 | $8 | $31 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 232 | $143 | $391 |
| Regadenoson injection (Lexiscan) for heart stress test | 216 | $48 | $100 |
| Laser destruction of incompetent vein of arm or leg using imaging guidance | 144 | $747 | $2,224 |
| Hospital follow-up visit, moderate complexity | 137 | $62 | $163 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 136 | $92 | $248 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 121 | $28 | $89 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 120 | $19 | $67 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 109 | $10 | $46 |
| Injection of chemical agent into multiple incompetent veins of leg | 106 | $203 | $546 |
| Ultrasonic guidance for needle placement | 106 | $46 | $209 |
| Remote patient monitoring device, 30 days | 81 | $30 | $180 |
| New patient office visit (45-59 min) | 79 | $127 | $325 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 68 | $59 | $78 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 66 | $17 | $41 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 66 | $11 | $27 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 63 | $43 | $350 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 54 | $234 | $1,465 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 53 | $17 | $50 |
| Echocardiogram, transthoracic | 49 | $124 | $1,376 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 45 | $174 | $232 |
| Initial hospital admission, moderate complexity | 39 | $103 | $257 |
| Ultrasound of both sides of head and neck blood flow | 38 | $71 | $351 |
| Coronary stent placement | 37 | $422 | $1,651 |
| Ultrasound of leg arteries or artery grafts | 32 | $53 | $248 |
| Cardiac catheterization | 30 | $779 | $9,290 |
| Remote patient monitoring management, 20 min/month | 30 | $37 | $150 |
| Initial hospital admission, high complexity | 25 | $136 | $426 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 23 | $1,083 | $3,800 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 19 | $9 | $150 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 19 | $16 | $150 |
| Evaluation of cardiac rhythm monitor system | 15 | $36 | $106 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 14 | $55 | $156 |
| Insertion of tube in coronary artery for diagnosis with review by radiologist | 11 | $165 | $2,579 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 11 | $208 | $1,120 |
| Ultrasound study of arm and leg arteries | 11 | $22 | $221 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.3% high complexity
34.5% medium
64.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$29,033
Total received (2018-2024)
Avg $4,148/year across 7 years
Top 17% in TX for orthopedic surgery
44
Companies
526
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$28,334 (97.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$461 (1.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$238 (0.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,604
2023$5,963
2022$1,986
2021$1,573
2020$1,887
2019$3,040
2018$12,980
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$5,530
Penumbra, Inc.
$4,928
Medtronic Vascular, Inc.
$2,606
BOSTON SCIENTIFIC CORPORATION
$2,447
Philips Electronics North America Corporation
$2,004
Terumo Medical Corporation
$1,467
Amarin Pharma Inc.
$1,370
Merit Medical Systems Inc
$1,339
ABIOMED
$888
AngioDynamics, Inc.
$780
Medtronic, Inc.
$595
Medicure Pharma Inc.
$461
Amgen Inc.
$451
Novartis Pharmaceuticals Corporation
$415
AstraZeneca Pharmaceuticals LP
$368
Boston Scientific Corporation
$358
Boehringer Ingelheim Pharmaceuticals, Inc.
$323
PFIZER INC.
$235
Janssen Pharmaceuticals, Inc
$225
E.R. Squibb & Sons, L.L.C.
$213
Merck Sharp & Dohme LLC
$185
Gilead Sciences, Inc.
$161
Shockwave Medical, Inc
$153
Teleflex LLC
$150
Corindus Inc.
$147
BIOTRONIK INC.
$144
Kowa Pharmaceuticals America, Inc.
$133
PORTOLA PHARMACEUTICALS, INC.
$120
Cardinal Health 200, LLC
$116
Intact Vascular, Inc.
$114
Lexicon Pharmaceuticals, Inc.
$109
Bard Peripheral Vascular, Inc.
$76
ARBOR PHARMACEUTICALS, INC.
$65
Siemens Medical Solutions USA, Inc.
$59
Arbor Pharmaceuticals, Inc.
$55
Bayer HealthCare Pharmaceuticals Inc.
$53
Itamar Medical Inc
$43
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$37
Regeneron Healthcare Solutions, Inc.
$23
Esperion Therapeutics, Inc.
$19
SCPHARMACEUTICALS INC.
$19
Actelion Pharmaceuticals US, Inc.
$18
Cardiovascular Systems Inc.
$16
Tactile Systems Technology Inc
$14
Top 3 companies account for 45.0% of total payments
Associated products mentioned in payments ›
(6577) Visions 014 · 3F · ABRE · ANDEXXA · AURYON LASER SYSTEM 100-120 VAC · Absolute Pro vascular stent system · Advisa · Amplia MRI · Artis Q · Asahi Fielder coronary guide wire · Auryon Laser System 100-120 Vac · Azure · BRILINTA · Biofreedom (DES) · CAMZYOS · CHANTIX · CLOSUREFAST · COMET · COREVALVE EVOLUT R · COROFLOW · Catheter - GuideLiner · ClosureFast · Comet · Confirm Rx · Connectivity and Remote care · CoreValve Evolut · Corlanor · DIAMONDBACK PERIPHERAL · ELIQUIS · ENTRESTO · Edarbi · Edarbyclor · Emboshield NAV6 system · FARXIGA · FLEXITOUCH · FUROSCIX · GENERAL - VASCULAR INTERVENTION · GENERAL METALLIC STENTS · GENERAL STENTS · GUIDEZILLA · General - Vascular Intervention · HAWKONE · HawkOne · Hi-Torque Command guide wire · IGT_D Peripheral · ILAB · IN.PACT ADMIRAL · IN.PACT Admiral · IVUS Systems · Image Guided Therapy Devices _ Peripheral · Impella · Indigo · Indigo System · Inpefa · JARDIANCE · JETI · JETI ALL IN ONE NON-STERILE KIT · JETI PERIPHERAL CATHETER · Kerendia · LEQVIO · Lasers · LifeVest · Livalo · MRI Ready Leads · Merlin Connectivity and Remote · NEXLETOL · Navicross · OPTICROSS · Omnilink Elite vascular stent system · Omnilink biliary stent systems · OptiCross · Optitorque · PERCLOSE PROGLIDE · PRALUENT · Perclose ProGlide suture mediated closure system · Peripheral Orbital Atherectomy System · Polaris X · Prelude Ideal Hydrophilic Sheath Introducer · Quadra Assura CRT Defibrillator · RESOLUTE ONYX · ROTABLATOR · Ranexa · Repatha · Reveal LINQ · SUPERA · SYNERGY · Solia · Stellarex · Supera peripheral stent system · Tack Endovascular System · TurboHawk · ULTRAVERSE · ULTREON · UPTRAVI · VENACURE 1470 PRO · VENASEAL · VENOVO · VERQUVO · VERSASEAL · VYNDAQEL · Vascepa · Vascular Lithotripsy · VenaCure 1470 Pro · Viance · WATCHMAN · WatchPAT · XARELTO · XIENCE SIERRA · Xience Sierra Coronary Stent · Xience Sierra Coronary Stent System · ZYPITAMAG (pitavastatin)
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $294 per 100 Medicare services performed
Geographic Context
Orthopedic Surgerys within 10 mi
24
Per 100K population
20.6
County median income
$50,448
Nearest hospital
NORTHWEST TEXAS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Haddad is a clinical cardiology specialist, with above-average Medicare volume (top 2% in TX), and high industry engagement (low-engagement, top 17%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Haddad experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Haddad performed 2,215 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Haddad receive payments from pharmaceutical companies?
Yes. Dr. Haddad received a total of $29,033 from 44 companies across 526 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Haddad's costs compare to other orthopedic surgerys in Amarillo?
Dr. Haddad's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Haddad) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Orthopedic Surgery
Common procedures, typical costs, and what industry payments mean in orthopedic surgery.
Same specialty & city
Orthopedic Surgerys in Amarillo
Browse orthopedic surgerys in Amarillo ranked by procedure volume and transparency data.
Highest volume
Top Orthopedic Surgerys in TX
Orthopedic Surgerys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Orthopedic Surgerys in TX
Which TX orthopedic surgerys receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
Penumbra, Inc. Payments to Doctors
See all physicians who received payments from Penumbra, Inc..
By company
Medtronic Vascular, Inc. Payments to Doctors
See all physicians who received payments from Medtronic Vascular, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology